» Articles » PMID: 11179007

Spectrum of Perforin Gene Mutations in Familial Hemophagocytic Lymphohistiocytosis

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 2001 Feb 17
PMID 11179007
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive disease of early childhood characterized by nonmalignant accumulation and multivisceral infiltration of activated T lymphocytes and histiocytes (macrophages). Cytotoxic T and natural killer (NK) cell activity is markedly reduced or absent in these patients, and mutations in a lytic granule constituent, perforin, were recently identified in a number of FHL individuals. Here, we report a comprehensive survey of 34 additional patients with FHL for mutations in the coding region of the perforin gene and the relative frequency of perforin mutations in FHL. Perforin mutations were identified in 7 of the 34 families investigated. Six children were homozygous for the mutations, and one patient was a compound heterozygote. Four novel mutations were detected: one nonsense, two missense, and one deletion of one amino acid. In four families, a previously reported mutation at codon 374, causing a premature stop codon, was identified, and, therefore, this is the most common perforin mutation identified so far in FHL patients. We found perforin mutations in 20% of all FHL patients investigated (7/34), with a somewhat higher prevalence, approximately 30% (6/20), in children whose parents originated from Turkey. No other correlation between the type of mutation and the phenotype of the patients was evident from the present study. Our combined results from mutational analysis of 34 families and linkage analysis of a subset of consanguineous families indicate that perforin mutations account for 20%-40% of the FHL cases and the FHL 1 locus on chromosome 9 for approximately 10%, whereas the major part of the FHL cases are caused by mutations in not-yet-identified genes.

Citing Articles

Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis: A Case Report of a Rare and Life-Threatening Syndrome.

Al-Anbagi U, Nashwan A, Isabirye C Cureus. 2025; 16(12):e76604.

PMID: 39886709 PMC: 11779568. DOI: 10.7759/cureus.76604.


Expansion and Precise CRISPR-Cas9 Gene Repair of Autologous T-Memory Stem Cells from Patients with T-Cell Immunodeficiencies.

Li X, Chu V, Kocks C, Rajewsky K Bio Protoc. 2024; 14(20):e5085.

PMID: 39512884 PMC: 11540044. DOI: 10.21769/BioProtoc.5085.


Genetic background of primary and familial HLH in Qatar: registry data and population study.

Elgaali E, Mezzavilla M, Ahmed I, Elanbari M, Ali A, Abdelaziz G Front Pediatr. 2024; 12:1326489.

PMID: 38808104 PMC: 11130942. DOI: 10.3389/fped.2024.1326489.


Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

Kogl T, Chang H, Staniek J, Chiang S, Thoulass G, Lao J J Exp Med. 2024; 221(7).

PMID: 38722309 PMC: 11082451. DOI: 10.1084/jem.20221122.


Hemophagocytic Lymphohistiocytosis (HLH) Flare Following the COVID-19 Vaccine: A Case Report.

Iqbal R, Bazaz A, Jafar A, Bajwa T, Devi K, Wilson J Cureus. 2024; 16(3):e56773.

PMID: 38650781 PMC: 11034401. DOI: 10.7759/cureus.56773.


References
1.
Stepp S, Le Deist F, Bhawan S, Certain S, Mathew P, Henter J . Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 1999; 286(5446):1957-9. DOI: 10.1126/science.286.5446.1957. View

2.
Yasukawa M, Ohminami H, Arai J, Kasahara Y, Ishida Y, Fujita S . Granule exocytosis, and not the fas/fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4(+) as well as CD8(+) cytotoxic T lymphocytes in humans. Blood. 2000; 95(7):2352-5. View

3.
Graham G, Graham L, Bridge P, Maclaren L, Wolff JEA , Coppes M . Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH). Pediatr Res. 2000; 48(2):227-32. DOI: 10.1203/00006450-200008000-00017. View

4.
Janka G . Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr. 1983; 140(3):221-30. DOI: 10.1007/BF00443367. View

5.
Perez N, Virelizier J, Fischer A, Griscelli C . Impaired natural killer activity in lymphohistiocytosis syndrome. J Pediatr. 1984; 104(4):569-73. DOI: 10.1016/s0022-3476(84)80549-1. View